AbbVie, Bristol Myers, Merck among latest to announce U.S. drug pricing deals: Reuters
Source: SeekingAlpha
2025-12-19 06:53:48 ET
More on Merck, AbbVie, etc.
- Merck's Deep Pipeline And Cash Flow Strength Support The Bull Case
- Bristol-Myers Squibb Company (BMY) Shareholder/Analyst Call Transcript
- Bristol-Myers Squibb Company (BMY) Shareholder/Analyst Call - Slideshow
- Medicare-negotiated drug prices to halve out-of-pocket costs next year: report
- Merck raised to Outperform at BMO on readiness for Keytruda patent cliff
Read the full article on Seeking Alpha
For further details see:
AbbVie, Bristol Myers, Merck among latest to announce U.S. drug pricing deals: Reuters
Novartis AG
NASDAQ: NVS
NVS Trading
-1.36% G/L:
$143.37 Last:
954,184 Volume:
$144.01 Open:
NVS Latest News
February 24, 2026 04:52:00 pm
Could Novartis Stock Quietly Help You Build a Millionaire Retirement Portfolio?
NVS Stock Data
$303,205,301,793
1,889,070,162
N/A
868
N/A
Pharmaceuticals
Healthcare
CH
Basel
